Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
85.49
-3.23 (-3.64%)
Mar 31, 2025, 9:47 AM EDT - Market open
Blueprint Medicines Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$124.29
Upside
+45.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Initiates $120 → $100 | Hold | Initiates | $120 → $100 | +16.97% | Mar 20, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +57.91% | Mar 17, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $150 | Buy | Initiates | $150 | +75.46% | Mar 7, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $125 | Buy | Reiterates | $125 | +46.22% | Mar 3, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +46.22% | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $133 | Strong Buy | Reiterates | $133 | +55.57% | Feb 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +57.91% | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $133 | Strong Buy | Reiterates | $133 | +55.57% | Feb 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $126 → $129 | Buy | Maintains | $126 → $129 | +50.89% | Feb 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $109 → $119 | Hold | Maintains | $109 → $119 | +39.20% | Jan 27, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +46.22% | Jan 15, 2025 |
| Wedbush | Wedbush | Buy Reiterates $135 → $124 | Buy | Reiterates | $135 → $124 | +45.05% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +57.91% | Jan 13, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $140 | Buy | Reiterates | $140 | +63.76% | Jan 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +57.91% | Dec 17, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.